Company profile for Terav

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TERAV, launched in 2022 under Spain?s Carlos III Institute with EU Recovery Plan funds, is a national network advancing personalized medicine through Advanced Therapy Medicinal Products (ATMPs). It targets rare and common diseases like monogenic disorders, leukemias, and inflammatory conditions. Comprising 32 research groups across 11 centers and 358 experts in gene/cell therapy, CAR-T, stem cells, and tissue engineering, TERA...
TERAV, launched in 2022 under Spain?s Carlos III Institute with EU Recovery Plan funds, is a national network advancing personalized medicine through Advanced Therapy Medicinal Products (ATMPs). It targets rare and common diseases like monogenic disorders, leukemias, and inflammatory conditions. Comprising 32 research groups across 11 centers and 358 experts in gene/cell therapy, CAR-T, stem cells, and tissue engineering, TERAV bridges lab research and clinical trials. Supported by 19 clinical groups, it accelerates translational therapies for unmet medical needs in children and adults.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Spain
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty